Trials / Recruiting
RecruitingNCT00230620
Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families With Pulmonary Arteriovenous Malformations
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will examine genes involved in the vascular dysplasia Hereditary haemorrhagic telangiectasia i(HHT)
Detailed description
Hereditary haemorrhagic telangiectasia (HHT) is a condition inherited as an autosomal dominant trait. Sequencing DNA from affected and unaffected family members allows us to identify disease-causal genes. Sequencing these genes allows us to identify what the precise DNA variants are which are causing disease, particularly if linked to functional assays in separate studies.
Conditions
Timeline
- Start date
- 1998-12-01
- Primary completion
- 2030-04-01
- Completion
- 2030-04-01
- First posted
- 2005-10-03
- Last updated
- 2023-09-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00230620. Inclusion in this directory is not an endorsement.